A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells

被引:35
作者
Lutzker, SG [1 ]
Mathew, R
Taller, DR
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, New Brunswick, NJ 08901 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Genet & Microbiol, New Brunswick, NJ 08901 USA
[4] Univ Med & Dent New Jersey, Inst Canc, New Brunswick, NJ 08901 USA
关键词
p53; apoptosis; DNA damage; teratocarcinoma cells;
D O I
10.1038/sj.onc.1204394
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Teratocarcinomas are tumors that arise from primordial germ cells and are readily curable with DNA-damaging chemotherapeutic drugs. Teratocarcinoma cells ex vivo in tissue culture are also relatively chemosensitive and undergo apoptotic death in response to DNA damage, We have previously hypothesized that the observed sensitivity of this tumor type to DNA damage is related to high basal expression of wild-type p53 protein, We have now addressed this issue by characterizing the DNA damage response of isogenic teratocarcinoma cells that differ only in their level of expression of wild-type p53 protein, We find a clear p53 dose-response relationship in these cells for rapid apoptosis following DNA damage that correlates with diminished colony formation in clonogenic survival assays. These results suggest that strategies to increase basal wild-type p53 protein expression prior to treatment with DNA-damaging drugs may improve curability in other tumor types. Oncogene (2001) 20, 2982-2986.
引用
收藏
页码:2982 / 2986
页数:5
相关论文
共 26 条
[1]   TESTICULAR TISSUE-SPECIFIC EXPRESSION OF THE P53 SUPPRESSOR GENE [J].
ALMON, E ;
GOLDFINGER, N ;
KAPON, A ;
SCHWARTZ, D ;
LEVINE, AJ ;
ROTTER, V .
DEVELOPMENTAL BIOLOGY, 1993, 156 (01) :107-116
[2]  
Brown JM, 1999, CANCER RES, V59, P1391
[3]  
Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.0.CO
[4]  
2-S
[5]  
Chresta CM, 1996, CANCER RES, V56, P1834
[6]   P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells [J].
Corbet, SW ;
Clarke, AR ;
Gledhill, S ;
Wyllie, AH .
ONCOGENE, 1999, 18 (08) :1537-1544
[7]  
Eid H, 1997, ANTICANCER RES, V17, P2663
[8]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[9]   A SIMPLE P53 FUNCTIONAL ASSAY FOR SCREENING CELL-LINES, BLOOD, AND TUMORS [J].
FLAMAN, JM ;
FREBOURG, T ;
MOREAU, V ;
CHARBONNIER, F ;
MARTIN, C ;
CHAPPUIS, P ;
SAPPINO, AP ;
LIMACHER, JM ;
BRON, L ;
BENHATTAR, J ;
TADA, M ;
VAN MEIR, EG ;
ESTREICHER, A ;
IGGO, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3963-3967
[10]   IDENTIFICATION OF AN UPSTREAM REGION OF THE MOUSE P53 PROMOTER CRITICAL FOR TRANSCRIPTIONAL EXPRESSION [J].
HALE, TK ;
BRAITHWAITE, AW .
NUCLEIC ACIDS RESEARCH, 1995, 23 (04) :663-669